ATE449174T1 - Neue peptide - Google Patents
Neue peptideInfo
- Publication number
- ATE449174T1 ATE449174T1 AT07006224T AT07006224T ATE449174T1 AT E449174 T1 ATE449174 T1 AT E449174T1 AT 07006224 T AT07006224 T AT 07006224T AT 07006224 T AT07006224 T AT 07006224T AT E449174 T1 ATE449174 T1 AT E449174T1
- Authority
- AT
- Austria
- Prior art keywords
- amino acid
- new peptides
- compound
- activity
- replaced
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract 1
- 102000018997 Growth Hormone Human genes 0.000 abstract 1
- 108010051696 Growth Hormone Proteins 0.000 abstract 1
- -1 amino acid compound Chemical class 0.000 abstract 1
- 229910001424 calcium ion Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000122 growth hormone Substances 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21000299 | 1999-07-23 | ||
JP33884199 | 1999-11-29 | ||
JP2000126623 | 2000-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE449174T1 true ATE449174T1 (de) | 2009-12-15 |
Family
ID=27329078
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07006224T ATE449174T1 (de) | 1999-07-23 | 2000-07-24 | Neue peptide |
AT00946453T ATE366813T1 (de) | 1999-07-23 | 2000-07-24 | Neue peptide |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00946453T ATE366813T1 (de) | 1999-07-23 | 2000-07-24 | Neue peptide |
Country Status (16)
Country | Link |
---|---|
US (5) | US7385026B1 (de) |
EP (3) | EP1197496B8 (de) |
JP (2) | JP3471780B2 (de) |
KR (1) | KR100827973B1 (de) |
CN (2) | CN100506844C (de) |
AT (2) | ATE449174T1 (de) |
AU (2) | AU784035B2 (de) |
BR (2) | BR0012688A (de) |
CA (2) | CA2380058C (de) |
CY (2) | CY1107724T1 (de) |
DE (2) | DE60043361D1 (de) |
DK (2) | DK1795598T3 (de) |
ES (3) | ES2288151T3 (de) |
IL (2) | IL147652A0 (de) |
PT (2) | PT1795598E (de) |
WO (1) | WO2001007475A1 (de) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE449174T1 (de) * | 1999-07-23 | 2009-12-15 | Kenji Kangawa | Neue peptide |
DE60042527D1 (de) | 1999-11-22 | 2009-08-20 | Zymogenetics Inc | Methode zur bildung einen peptid-rezeptor komplex mit zsig33 polypeptiden. |
US6897286B2 (en) | 2000-05-11 | 2005-05-24 | Zymogenetics, Inc. | Zsig33-like peptides |
US7141646B2 (en) | 2000-05-12 | 2006-11-28 | Kaneka Corporation | Method of purifying vinyl polymer |
US6967237B2 (en) | 2000-05-30 | 2005-11-22 | Merck & Co., Inc. | Ghrelin analogs |
WO2002008250A2 (en) * | 2000-07-24 | 2002-01-31 | Ardana Bioscience Limited | Ghrelin antagonists |
CN100491395C (zh) * | 2002-04-11 | 2009-05-27 | 阿斯比奥制药株式会社 | 修饰肽的制造方法 |
IL162796A0 (en) | 2002-05-21 | 2005-11-20 | Kenji Kangawa | Medicinal compositions containing ghrelin |
NZ537001A (en) * | 2002-07-19 | 2007-04-27 | Cytos Biotechnology Ag | A composition comprising a virus-like particle and at least ghrelin or a ghrelin-derived peptide bound thereto |
PL212106B1 (pl) * | 2002-07-23 | 2012-08-31 | Sod Conseils Rech Applic | Analogi greliny, ich zastosowanie oraz sposób identyfikacji związku zdolnego do wiązania się z receptorem GHS |
TWI331922B (en) | 2002-08-09 | 2010-10-21 | Ipsen Pharma Sas | Growth hormone releasing peptides |
CA2496687A1 (en) * | 2002-09-18 | 2004-04-01 | Centre Hospitalier De L'universite De Montreal (Chum) | Ghrh analogues |
EP1407779A1 (de) * | 2002-10-10 | 2004-04-14 | Gastrotech A/S | Verwendung von Ghrelin zur Behandlung von vermindertem Körpergewicht und Körperfett in Individuen mit Gastrektomie |
ATE550029T1 (de) * | 2003-04-30 | 2012-04-15 | Kenji Kangawa | Mittel zur prävention oder heilung von hepatopathie |
US20060269550A1 (en) * | 2003-06-04 | 2006-11-30 | Heiman Mark L | Anti-ghrelin fab antibodies |
US20060233788A1 (en) * | 2003-09-05 | 2006-10-19 | Heiman Mark L | Anti-ghrelin antibodies |
CN1321131C (zh) * | 2003-12-26 | 2007-06-13 | 李宁 | 猪Ghrelin衍生物及其编码基因与应用 |
BRPI0507002A (pt) * | 2004-01-20 | 2007-06-05 | Cytos Biotechnology Ag | conjugados veìculos de grelina |
US7026175B2 (en) | 2004-03-29 | 2006-04-11 | Applied Materials, Inc. | High throughput measurement of via defects in interconnects |
WO2005097173A2 (en) * | 2004-04-07 | 2005-10-20 | Gastrotech Pharma A/S | Use of ghrelin for the treatment of hyperthyroidism |
WO2005097831A2 (en) * | 2004-04-07 | 2005-10-20 | Gastrotech Pharma A/S | Uses of isolated binding members capable of binding specifically to secretagogues |
WO2005097830A2 (en) * | 2004-04-07 | 2005-10-20 | Aditech Pharma Ab | Uses of isolated binding members capable of reducing the biological activity of secretagogue compounds |
US20080269116A1 (en) * | 2004-05-11 | 2008-10-30 | Taub Dennis D | Methods of Inhibiting Proinflammatory Cytokine Expression Using Ghrelin |
WO2005120484A1 (ja) * | 2004-06-09 | 2005-12-22 | Kurume University | グレリンの生理学的機能のレギュレーター |
JP2008515771A (ja) * | 2004-07-14 | 2008-05-15 | イーライ リリー アンド カンパニー | 抗グレリン抗体 |
WO2006045319A2 (en) * | 2004-10-27 | 2006-05-04 | Gastrotech Pharma A/S | Uses of growth hormone secretagogues in the treatment of individuals suffering from renal and/or liver failure |
WO2006045313A2 (en) * | 2004-10-27 | 2006-05-04 | Gastrotech Pharma A/S | Uses of secretagogues for treatment of organ transplant patients |
US20080300180A1 (en) * | 2004-11-30 | 2008-12-04 | Gastrotech Pharma A/S | Growth Hormone Secretagogue Receptor 1A Ligands |
CN101128213B (zh) | 2005-02-23 | 2013-05-08 | 国立大学法人京都大学 | 胰腺β细胞再生的促进剂以及在胰腺β细胞中生产胰岛素的促进剂 |
EP1856154A1 (de) | 2005-02-23 | 2007-11-21 | Eli Lilly And Company | Humanisierte antighrelin-antikörper |
PL1937262T3 (pl) | 2005-09-29 | 2019-10-31 | Ipsen Pharma | Kompozycja do stosowania w leczeniu zaburzeń motoryki przewodu pokarmowego |
AU2006316100B2 (en) * | 2005-11-21 | 2011-12-01 | Daiichi Sankyo Company, Limited | Therapeutic agent for skin or skin repair-promoting agent comprising ghrelin, derivative thereof or substance capable of acting on GHS-R1a as active ingredient |
EP1967201A4 (de) * | 2005-11-21 | 2009-09-30 | Univ Miyazaki | Therapeutisches mittel für die haut oder die hautreparatur förderndes mittel mit des-acylghrelin oder ein derivat davon als wirkstoff |
US20100227806A1 (en) * | 2006-03-10 | 2010-09-09 | Tulipano Giovanni | Use Of A Ghrelin Agonist To Improve Catabolic Effects Of Glucocorticoid Treatment |
KR101201055B1 (ko) | 2006-03-13 | 2012-11-15 | 리아트 민쯔 | 악액질 및/또는 식욕감퇴 및/또는 식욕감퇴-악액질 및/또는영양장애 및/또는 지방이영양증 및/또는 근육 쇠약 및/또는 식욕-자극의 치료를 위한 그렐린 스플라이스 변이체의 용도 |
KR101510082B1 (ko) * | 2006-08-01 | 2015-04-10 | 더 스크립스 리서치 인스티튜트 | 비만증을 억제하기 위한 백신 및 방법 |
WO2008018600A1 (fr) | 2006-08-11 | 2008-02-14 | University Of Miyazaki | AGENT THÉRAPEUTIQUE PERMETTANT D'ACCÉLÉRER LA RÉPARATION DES NERFS RACHIDIENS COMPRENANT EN TANT QUE MATIÈRE ACTIVE DE LA GHRÉLINE, UN DÉRIVÉ DE CELLE-CI OU UNE SUBSTANCE CAPABLE D'AGIR SUR LE GHS-R1a |
RU2009108640A (ru) * | 2006-08-11 | 2010-09-20 | Юниверсити Оф Миязаки (Jp) | Лекарственные средства, усиливающие репарацию спинно-мозговых нервов, содержащие в качестве активного ингредиента дезацилгрелин или его производные |
US8299022B2 (en) * | 2006-09-27 | 2012-10-30 | Ipsen Pharma S.A.S. | Analogs of ghrelin substituted at the N-terminal |
CA2698582C (en) * | 2008-05-23 | 2016-09-13 | Asubio Pharma Co., Ltd. | Peptide having an extending action for half-life of object peptide in plasma |
CA2748314C (en) | 2009-02-03 | 2018-10-02 | Amunix Operating Inc. | Extended recombinant polypeptides and compositions comprising same |
WO2010132580A2 (en) * | 2009-05-12 | 2010-11-18 | The Administrators Of The Tulane Educational Fund | Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
US9724381B2 (en) | 2009-05-12 | 2017-08-08 | The Administrators Of The Tulane Educational Fund | Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
ES2599168T3 (es) | 2010-01-15 | 2017-01-31 | University Of Miyazaki | Grelina para promover la recuperación de un animal en tratamiento médico |
WO2011159917A2 (en) * | 2010-06-16 | 2011-12-22 | The Administrators Of The Tulane Educational Fund | Growth hormone secretatogue receptor antagonists and uses thereof |
JP5999712B2 (ja) | 2011-03-03 | 2016-09-28 | 国立大学法人 宮崎大学 | 高体温治療剤 |
JP5560248B2 (ja) * | 2011-09-07 | 2014-07-23 | 花王株式会社 | ジペプチド誘導体及びその製造方法 |
EA030911B1 (ru) | 2012-02-27 | 2018-10-31 | Амуникс Оперейтинг Инк. | Композиции конъюгата xten и способы их получения |
NZ701573A (en) | 2012-05-17 | 2017-04-28 | Extend Biosciences Inc | Carriers for improved drug delivery |
WO2014054798A1 (ja) | 2012-10-04 | 2014-04-10 | 独立行政法人国立循環器病研究センター | 悪性腫瘍転移抑制用医薬 |
WO2014065341A1 (ja) | 2012-10-24 | 2014-05-01 | 第一三共株式会社 | 筋萎縮性側索硬化症治療剤 |
WO2014119753A1 (ja) * | 2013-01-31 | 2014-08-07 | 学校法人 東京薬科大学 | マイオスタチン阻害ペプチド |
JP6295247B2 (ja) * | 2013-03-25 | 2018-03-14 | ゼリア新薬工業株式会社 | 食後期の胃運動亢進剤 |
US9616109B2 (en) | 2014-10-22 | 2017-04-11 | Extend Biosciences, Inc. | Insulin vitamin D conjugates |
US9585934B2 (en) | 2014-10-22 | 2017-03-07 | Extend Biosciences, Inc. | Therapeutic vitamin D conjugates |
US9789197B2 (en) | 2014-10-22 | 2017-10-17 | Extend Biosciences, Inc. | RNAi vitamin D conjugates |
CN109879935B (zh) * | 2019-03-04 | 2020-11-20 | 南京工业大学 | 一种多肽的液相合成方法 |
BR112022009217A2 (pt) | 2019-11-13 | 2022-08-02 | Amunix Pharmaceuticals Inc | Polipeptídeos xten com código de barras e composições destes, e métodos para produzir e usar os mesmos |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5194596A (en) * | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
EP0635025B1 (de) * | 1992-04-07 | 2002-11-06 | The Scripps Research Institute | Verfahren zur herstellung modifizierten proteine |
IL118473A0 (en) | 1995-06-02 | 1996-09-12 | Suntory Ltd | Staphylococcus aureus V8 protease genes coding therefor and a method for the production thereof |
JP3982866B2 (ja) | 1996-03-04 | 2007-09-26 | アスビオファーマ株式会社 | 分泌型Kex2誘導体の製造方法 |
CA2198966C (en) | 1996-03-04 | 2011-06-21 | Yuji Suzuki | Method for cleaving chimeric protein using processing enzyme |
WO1999063088A2 (en) * | 1998-06-02 | 1999-12-09 | Genentech, Inc. | Membrane-bound proteins and nucleic acids encoding the same |
BR9808059A (pt) | 1997-03-24 | 2000-03-08 | Zimogenetics Inc | Molécula de plinucleotìdeo isolada codificando um polipeptìdeo, polinucleotìdeo, vetor de expressão, célula cultivada, polipeptìdeo isolado, composição farmacêutica, anticorpo, processos para produzir polipeptìdeo zsig33, e, para estimular a motilidde gástrica |
US6420521B1 (en) * | 1999-06-30 | 2002-07-16 | Zymogenetics, Inc. | Short gastrointestinal peptides |
ATE449174T1 (de) | 1999-07-23 | 2009-12-15 | Kenji Kangawa | Neue peptide |
-
2000
- 2000-07-24 AT AT07006224T patent/ATE449174T1/de active
- 2000-07-24 CN CNB008104409A patent/CN100506844C/zh not_active Expired - Lifetime
- 2000-07-24 EP EP00946453A patent/EP1197496B8/de not_active Expired - Lifetime
- 2000-07-24 PT PT07006224T patent/PT1795598E/pt unknown
- 2000-07-24 CA CA2380058A patent/CA2380058C/en not_active Expired - Lifetime
- 2000-07-24 BR BR0012688-8A patent/BR0012688A/pt not_active IP Right Cessation
- 2000-07-24 WO PCT/JP2000/004907 patent/WO2001007475A1/ja active Application Filing
- 2000-07-24 ES ES00946453T patent/ES2288151T3/es not_active Expired - Lifetime
- 2000-07-24 DK DK07006224.5T patent/DK1795598T3/da active
- 2000-07-24 EP EP07006224A patent/EP1795598B1/de not_active Expired - Lifetime
- 2000-07-24 US US09/959,577 patent/US7385026B1/en not_active Expired - Lifetime
- 2000-07-24 BR BRPI0012688A patent/BRPI0012688B8/pt unknown
- 2000-07-24 ES ES07006224T patent/ES2335235T3/es not_active Expired - Lifetime
- 2000-07-24 DK DK00946453T patent/DK1197496T3/da active
- 2000-07-24 CN CN200910141231.3A patent/CN101693736B/zh not_active Expired - Lifetime
- 2000-07-24 JP JP2001512558A patent/JP3471780B2/ja not_active Expired - Lifetime
- 2000-07-24 CA CA2696819A patent/CA2696819C/en not_active Expired - Lifetime
- 2000-07-24 AT AT00946453T patent/ATE366813T1/de active
- 2000-07-24 EP EP09166974A patent/EP2119785B1/de not_active Expired - Lifetime
- 2000-07-24 IL IL14765200A patent/IL147652A0/xx unknown
- 2000-07-24 ES ES09166974T patent/ES2401939T3/es not_active Expired - Lifetime
- 2000-07-24 DE DE60043361T patent/DE60043361D1/de not_active Expired - Lifetime
- 2000-07-24 AU AU60231/00A patent/AU784035B2/en not_active Expired
- 2000-07-24 DE DE60035502T patent/DE60035502T2/de not_active Expired - Lifetime
- 2000-07-24 KR KR1020027000758A patent/KR100827973B1/ko active IP Right Grant
- 2000-07-24 PT PT00946453T patent/PT1197496E/pt unknown
-
2002
- 2002-01-15 IL IL147652A patent/IL147652A/en active IP Right Grant
-
2003
- 2003-07-07 JP JP2003271241A patent/JP4227857B2/ja not_active Expired - Lifetime
-
2006
- 2006-04-13 AU AU2006201580A patent/AU2006201580B2/en not_active Expired
-
2007
- 2007-08-28 CY CY20071101137T patent/CY1107724T1/el unknown
-
2008
- 2008-01-30 US US12/010,838 patent/US8227570B2/en not_active Expired - Fee Related
-
2010
- 2010-01-05 CY CY20101100012T patent/CY1109714T1/el unknown
- 2010-03-22 US US12/728,495 patent/US9573986B2/en not_active Expired - Fee Related
-
2011
- 2011-03-31 US US13/076,844 patent/US8524871B2/en not_active Expired - Fee Related
-
2012
- 2012-06-12 US US13/494,673 patent/US9938332B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE366813T1 (de) | Neue peptide | |
ATE458054T1 (de) | Menschliches parathyroidhormon, modifikationen, herstellung und verwendung | |
MXPA04005906A (es) | Cis-2,4,5-trifenil-.imidazolinas y uso de la misma para tratamiento de tumores. | |
ATE497390T1 (de) | Neue therapeutische verwendung von smr-1 peptide | |
ATE155486T1 (de) | Zyklische peptide und ihre verwendung | |
DK1079849T3 (da) | Anvendelse af HMG-proteiner til fremstilling af lægemidler med cytotoksisk virkning | |
EP0270214A3 (de) | Vasopressinantagonisten | |
DE602004023827D1 (de) | Ionenkanalaktivität hemmende niedrigmolekulare peptide | |
BR9712033A (pt) | Composição farmacêutica para tratamento de doenças virais. | |
DE50307025D1 (de) | Zubereitungen zur intranasalen applikation ausgewählter, von aminosäuren abgeleiteter cgrp-antagonisten | |
ATE441713T1 (de) | Tumorantigenprotein und dessen verwendung | |
GB0207644D0 (en) | Peptides and their use | |
ATE354646T1 (de) | Selektionsmarker | |
EP1760087A4 (de) | Neuer proteinkomplex und anwendungen davon | |
WO2003022300A1 (fr) | Remedes prophylactiques et curatifs contre les maladies des os et des articulations | |
ATE46173T1 (de) | Pharmakologisch aktive peptide. | |
DE60321443D1 (de) | Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung | |
ATE417061T1 (de) | Scorpionpeptid als blutdrucksenkendes mittel | |
TH18962A (th) | สารผสมที่ทำให้ขนร่วงซึ่งประกอบด้วยสารประกอบซัลฟ์ไฮดริล | |
TH26711A (th) | " สิ่งที่คล้ายกันของปัจจัยหลั่งฮอโมนของการเจริญเติบโต " | |
EP1308512A4 (de) | Neuartige proteine und deren dna | |
DE69508496D1 (de) | Endothelin-antagonisierendes Peptid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1795598 Country of ref document: EP |